We show for the first time that elevating SOX2 in tumor cells representing four different tumor types decreases the expression of a broad spectrum of cell cycle machinery, in particular cyclins and CDKs that control the transition of each phase of the cell cycle. The gene discussed is SOX2; the disease is neoplasm.